Orla antidiabetic drugs duration
Reading File
Quick answer: Oral antidiabetic drugs vary in their duration of action - sulfonylureas like glibenclamide last 12-24 hours, metformin is given 2-3 times daily, DPP-4 inhibitors like sitagliptin last ~24 hours, while newer SGLT2 inhibitors and GLP-1 agonists also have once-daily dosing.
Searching sources...
Finding Sources
Finding Sources
Finding Sources
Finding Sources
The best source is Katzung's Pharmacology. Let me read the antidiabetic drugs section.
Reading File
Finding Sources
Reading File
I found good content. Let me read from line 3850 to get the oral antidiabetic drugs section with sulfonylureas, meglitinides, etc.
Reading File
Excellent - I have very detailed content. Let me read a bit more to get GLP-1 agonists, DPP-4 inhibitors, SGLT2 inhibitors, and thiazolidinediones duration data.
Reading File
I now have comprehensive data from Katzung's Pharmacology. I have enough information to provide a thorough answer on the duration of action of oral antidiabetic drugs.
Here is a comprehensive overview of oral antidiabetic drugs and their duration of action, based on Katzung's Basic and Clinical Pharmacology (16th ed.):
Oral Antidiabetic Drugs - Duration of Action
1. Sulfonylureas (Insulin Secretagogues)
These stimulate insulin release by binding to ATP-sensitive K+ channels on beta cells.
First-Generation:
| Drug | Duration of Action |
|---|---|
| Tolbutamide | 6-12 hours (shortest; given 2-3x/day) |
| Tolazamide | 12-24 hours (intermediate) |
| Chlorpropamide | Up to 60 hours (longest; given once daily) |
| Acetohexamide | 12-18 hours |
Second-Generation:
| Drug | Duration of Action |
|---|---|
| Glipizide | 10-16 hours (regular); extended-release: ~24 hours |
| Glibenclamide (Glyburide) | 18-24 hours |
| Glimepiride | ~24 hours (once daily) |
| Gliclazide | 10-15 hours (regular); modified-release: ~24 hours |
Note: Second-generation sulfonylureas have greater receptor affinity and lower effective doses. They are metabolized by the liver; metabolites are excreted renally and via bile. - Katzung's Basic and Clinical Pharmacology, 16th ed., p. 1184
2. Meglitinide Analogs (Rapid-Acting Insulin Secretagogues)
Same mechanism as sulfonylureas but shorter-acting; taken with meals.
| Drug | Duration of Action |
|---|---|
| Repaglinide | 4-7 hours (peak effect ~1 hour after ingestion) |
| Nateglinide | 1-2 hours (very short; given just before each meal) |
"Repaglinide has a fast onset of action, with a peak concentration and peak effect within approximately 1 hour after ingestion, but the duration of action is 4-7 hours." - Katzung's, p. 1186
3. Biguanides
| Drug | Duration / Dosing |
|---|---|
| Metformin | Half-life: 1.5-3 hours; given 2-3x/day. Extended-release formulation allows once-daily dosing. |
"Metformin has a half-life of 1.5-3 hours, is not bound to plasma proteins, is not metabolized, and is excreted by the kidneys as the active compound." - Katzung's, p. 1187
Maximum effective dose is ~2000 mg/day despite the recommended maximum of 2550 mg. Common schedule: 500-1000 mg twice daily.
4. Thiazolidinediones (TZDs / Glitazones)
Act via PPARgamma nuclear receptors; effects take days to weeks to manifest fully.
| Drug | Duration of Action |
|---|---|
| Pioglitazone | ~24 hours (once daily); full glycemic effect takes several weeks |
| Rosiglitazone | ~24 hours (once daily or divided) |
5. Alpha-Glucosidase Inhibitors
Act locally in the gut to delay carbohydrate absorption; taken with each meal.
| Drug | Duration of Action |
|---|---|
| Acarbose | 4-6 hours; must be taken with the first bite of each meal |
| Miglitol | 4-6 hours; taken with meals |
6. DPP-4 Inhibitors (Gliptins)
Increase endogenous GLP-1 by blocking its degradation.
| Drug | Duration of Action |
|---|---|
| Sitagliptin | ~24 hours (once daily) |
| Saxagliptin | ~24 hours (once daily) |
| Vildagliptin | ~12 hours (twice daily) |
| Alogliptin | ~24 hours (once daily) |
| Linagliptin | ~24 hours (once daily) |
7. SGLT2 Inhibitors (Gliflozins)
Block renal glucose reabsorption; also cardio- and nephroprotective.
| Drug | Duration of Action |
|---|---|
| Empagliflozin | ~24 hours (once daily) |
| Dapagliflozin | ~24 hours (once daily) |
| Canagliflozin | ~24 hours (once daily) |
8. GLP-1 Receptor Agonists (Injectable but worth comparing)
| Drug | Duration of Action |
|---|---|
| Exenatide (twice daily) | ~10 hours (peak ~2 hours) |
| Liraglutide | ~24 hours (once daily) |
| Semaglutide (oral/injectable) | ~7 days (once weekly injectable) |
| Dulaglutide | ~7 days (once weekly) |
"It [exenatide] reaches a peak concentration in approximately 2 hours with a duration of action of up to 10 hours." - Katzung's, p. 1186
Summary Table
| Class | Examples | Typical Duration |
|---|---|---|
| 1st-gen Sulfonylureas | Tolbutamide, Chlorpropamide | 6-60 hours |
| 2nd-gen Sulfonylureas | Glipizide, Glyburide, Glimepiride | 10-24 hours |
| Meglitinides | Repaglinide, Nateglinide | 1-7 hours |
| Biguanides | Metformin | 1.5-3 hr half-life; dosing 2-3x/day |
| TZDs | Pioglitazone | ~24 hours; weeks for full effect |
| Alpha-glucosidase inhibitors | Acarbose, Miglitol | 4-6 hours (with each meal) |
| DPP-4 inhibitors | Sitagliptin, Linagliptin | ~24 hours |
| SGLT2 inhibitors | Empagliflozin, Dapagliflozin | ~24 hours |
Key clinical points:
- Chlorpropamide (60 hr duration) carries the highest risk of prolonged hypoglycemia
- Meglitinides are ideal for postprandial glucose control due to short duration
- SGLT2 inhibitors and DPP-4 inhibitors offer once-daily dosing with low hypoglycemia risk
- Metformin is first-line for type 2 DM and has additional cardiovascular/renal benefits when combined with SGLT2 inhibitors
Sources: Katzung's Basic and Clinical Pharmacology, 16th Edition, Chapter 41
This is a shared conversation. Sign in to Orris to start your own chat.